EC Clinical and Medical Case Reports

Case Report Volume 7 Issue 9 - 2024

Campylobacter Colitis Presenting as a Mimic of Inflammatory Bowel Disease (IBD) - Case Report

Ahmed Elmansi*

Paediatric Trainee, East-Midlands School of Paediatric, Leicester, United Kingdom

*Corresponding Author: Ahmed Elmansi Paediatric Trainee, East-Midlands School of Paediatric, Leicester, United Kingdom.
Received: August 01, 2024; Published: August 27, 2024



Background: Campylobacter infection in children is relatively common and can present with symptoms similar to those of inflammatory bowel disease (IBD), intussusception, and appendicitis. Campylobacter infection can lead to immune-mediated complications, including Guillain-Barré syndrome (GBS) and reactive arthritis.

Case Presentation: A 17-year-old girl presented with a three-day history of fever, right iliac fossa pain, vomiting, and bloody diarrhea. An abdominal ultrasound revealed inflammatory changes in the terminal part of the ileum and proximal part of the cecum. CT scan of the abdomen and pelvis revealed concentric thickening of the terminal ileal wall, as well as wall thickening and loss of normal haustrations in the sigmoid colon. Suspecting inflammatory bowel disease (IBD), steroids were initially recommended. However, stool culture results came back positive for Campylobacter jejuni, leading to the discontinuation of steroid therapy and the initiation of ciprofloxacin. Within three days, her symptoms improved, and she was discharged home.

Conclusion: Infectious colitis caused by Campylobacter is a common condition that can present with symptoms similar to those of inflammatory bowel disease (IBD), intussusception, and appendicitis. It is essential to exclude infectious causes, including Campylobacter, before conducting extensive investigations for other differential diagnoses.

 Keywords: Inflammatory Bowel Disease (IBD); Intussusception; Campylobacter Infection; Guillain-Barré Syndrome (GBS)

  1. Centers for Disease Control and Prevention. “Foodborne Diseases Active Surveillance Network (FoodNet): FoodNet 2015 Surveillance Report (Final Data)”. Atlanta, GA: US Department of Health and Human Services, CDC (2017).
  2. Blaser MJ., et al. “Campylobacter enteritis: clinical and epidemiologic features”. Annals of Internal Medicine 2 (1979): 179-185.
  3. Karmali MA and Fleming PC. “Campylobacter enteritis in children”. Journal of Pediatrics 4 (1979): 527-533.
  4. Jones PH., et al. “Campylobacter enteritis associated with the consumption of free school milk”. Journal of Hygiene (London)2 (1981): 155-162.
  5. Levy I., et al. “Acute encephalopathy associated with Campylobacter enteritis”. British Medical Journal (Clinical Research Edition) 6544 (1986): 424.
  6. Femández-Cruz A., et al. “Campylobacter bacteremia: clinical characteristics, incidence, and outcome over 23 years”. Medicine (Baltimore)5 (2010): 319-330.
  7. Tee W and Mijch A. “Campylobacter jejuni bacteremia in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients: comparison of clinical features and review”. Clinical Infectious Diseases 1 (1998): 91-96.
  8. Smith GS and Blaser MJ. “Fatalities associated with Campylobacter jejuni infections”. Journal of the American Medical Association 19 (1985): 2873-2875.
  9. Freedman SB., et al. “Treatment of acute gastroenteritis in children: an overview of systematic reviews of interventions commonly used in developed countries”. Evidence-Based Child Health 4 (2013): 1123-1137.
  10. Lazzerini M and Wanzira H. “Oral zinc for treating diarrhoea in children”. Cochrane Database of Systematic Reviews 12 (2016): CD005436.

Ahmed Elmansi. "Campylobacter Colitis Presenting as a Mimic of Inflammatory Bowel Disease (IBD) - Case Report." EC Clinical and Medical Case Reports 7.9 (2024): 01-03.